Literature DB >> 9286233

Lack of hepatocyte growth factor receptor (c-met) gene expression in fulminant hepatic failure livers before transplantation.

J Y Ljubimova1, L M Petrovic, N Arkadopoulos, P Blanc, S A Geller, A A Demetriou.   

Abstract

To gain insight into liver regeneration mechanisms in fulminant hepatic failure, we compared gene expression of hepatocyte growth factor, its receptor c-met, c-myc, and albumin in human normal (4 cases) and fulminant (14 cases) livers by reverse transcription-polymerase chain reaction. In normal livers, hepatocyte growth factor gene was not expressed, whereas c-met, c-myc and albumin genes were always expressed. In fulminant hepatic failure, hepatocyte growth factor gene was expressed in 1 of 14 cases, c-met in none of 14 cases, c-myc in 10 of 14 cases, and albumin in 3 of 14 cases. By immunofluorescence, c-met protein was revealed in normal but not in fulminant hepatic failure liver tissue. Liver tissue is unlikely to account for high hepatocyte growth factor plasma levels typical for fulminant hepatic failure. Lack of its receptor (c-met) expression may explain a poor response of fulminant hepatic failure livers to exogenous hepatocyte growth factor that normally promotes liver growth and regeneration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9286233     DOI: 10.1023/a:1018805330280

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Smooth muscle-derived factor stimulates mobility of human tumor cells.

Authors:  E M Rosen; L Meromsky; E Setter; D W Vinter; I D Goldberg
Journal:  Invasion Metastasis       Date:  1990

2.  Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure--a multicenter European study.

Authors:  M P Chenard-Neu; K Boudjema; J Bernuau; C Degott; J Belghiti; D Cherqui; V Costes; J Domergue; F Durand; J Erhard; B De Hemptinne; G Gubernatis; A Hadengue; J Kemnitz; M McCarthy; H Maschek; G Mentha; K Oldhafer; B Portmann; M Praet; J Ringers; X Rogiers; L Rubbia; S Schalm; J P Bellocq
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

3.  Amplification and enhanced expression of the c-myc oncogene in mouse SEWA tumour cells.

Authors:  M Schwab; G Ramsay; K Alitalo; H E Varmus; J M Bishop; T Martinsson; G Levan; A Levan
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

4.  Serum hepatocyte growth factor levels in liver diseases: clinical implications.

Authors:  G Shiota; J Okano; H Kawasaki; T Kawamoto; T Nakamura
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

5.  Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions.

Authors:  W F Grigioni; M Fiorentino; A D'Errico; A Ponzetto; T Crepaldi; M Prat; P M Comoglio
Journal:  Hepatology       Date:  1995-06       Impact factor: 17.425

6.  Histopathological heterogeneity in fulminant hepatic failure.

Authors:  C Hanau; S J Munoz; R Rubin
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.

Authors:  L Naldini; E Vigna; R P Narsimhan; G Gaudino; R Zarnegar; G K Michalopoulos; P M Comoglio
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

9.  Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure.

Authors:  H Tsubouchi; S Hirono; E Gohda; H Nakayama; K Takahashi; O Sakiyama; H Miyazaki; J Sugihara; E Tomita; Y Muto
Journal:  Hepatology       Date:  1989-06       Impact factor: 17.425

10.  Clinical significance of serum hepatocyte growth factor in orthotopic liver transplantation.

Authors:  C Miki; K Iriyama; A Strain; J D Harrison; S Hirono; B K Gunson; J M Sherwell; H Sunsuki; P McMaster
Journal:  Surgery       Date:  1996-05       Impact factor: 3.982

View more
  2 in total

1.  Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas.

Authors:  Mehrnoosh Saghizadeh; Andrei A Kramerov; Jian Tajbakhsh; Annette M Aoki; Charles Wang; Ning-Ning Chai; Julia Y Ljubimova; Takako Sasaki; Gabriel Sosne; Marc R J Carlson; Stanley F Nelson; Alexander V Ljubimov
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

2.  Hepatic expression of hepatocyte growth factor gene mRNA in acute liver failure.

Authors:  P Harrison; C Gove; A Bomford
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.